The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development

Recent epidemiological studies show that postmenopausal women taking estrogen-progestin hormone replacement therapy (HRT) have a higher risk of breast cancer than women on an HRT regimen lacking progestins. This may be related to the observation that progestin-treated breast cancer cells express and...

Descripción completa

Detalles Bibliográficos
Autores principales: CARROLL, CANDACE E., LIANG, YAYUN, BENAKANAKERE, INDIRA, BESCH-WILLIFORD, CYNTHIA, HYDER, SALMAN M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583650/
https://www.ncbi.nlm.nih.gov/pubmed/23123638
http://dx.doi.org/10.3892/ijo.2012.1675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583650/
https://www.ncbi.nlm.nih.gov/pubmed/23123638
http://dx.doi.org/10.3892/ijo.2012.1675

Ejemplares similares